Open AccessA standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)
Author(s) -
B A Pooja,
Santosh Kumar Bhatted
Publication year - 2016
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/ayu.ayu_14_15
Subject(s) - karma , dyslipidemia , medicine , philosophy , theology , obesity , buddhism
Dyslipidemia, a major risk factor of coronary heart disease, is the leading single cause of death in the world. Currently available hypolipidemic agents have been associated with a large number of side effects. The radical Ayurveda Samshodhana Chikitsa as a treatment protocol can provide better effect. Therefore, the present study was designed to evaluate the effect of Virechana Karma and Lekhana Basti in dyslipidemia.